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With vast and diverse terrains, harsh climates, and large populations of wild and domestic animals, Mongolia is home to numerous zoonotic disease problems. Influenza A viruses have caused considerable morbidity and deaths to horses and migrating birds. Approximately every 10 years, Mongolia experiences large epizootics of equine influenza virus (EIV) among its 2·1 million horses.[1](#irv12148-bib-0001){ref-type="ref"} Anecdotal reports suggest that Mongolian children become sick when horses are sick with EIV. Since first detections were noted in 2005, Mongolia\'s large migrating bird populations harbor both highly pathogenic and low pathogenic avian influenza viruses (AIV).[2](#irv12148-bib-0002){ref-type="ref"}, [3](#irv12148-bib-0003){ref-type="ref"}, [4](#irv12148-bib-0004){ref-type="ref"}, [5](#irv12148-bib-0005){ref-type="ref"} As both EIV[6](#irv12148-bib-0006){ref-type="ref"} and AIV are known to infect man, we sought to study Mongolians for evidence of EIV and AIV infection.

Methods {#irv12148-sec-0002}
=======

Four institutional review boards approved the study. Eligible participants (≥18 years old and self‐reporting no immunocompromising conditions) were recruited from seven soums (counties) within three aimags (provinces; Figure [1](#irv12148-fig-0001){ref-type="fig"}). In general, participants worked in livestock, agriculture, and mining industries. Consenting participants were interviewed at their home by study staff who completed enrollment forms and collected blood samples via venipuncture. Demographic information and medical history, including prior receipt of influenza vaccines and recent respiratory illness history, were assessed. Participants reported community, household, and occupational animal exposures. Reports of disease outbreaks in the participants\' flocks/herds were also recorded. Data from the enrollment questionnaire were used to dichotomously classify domestic and wild animal exposures based upon a cut point of ≥5 cumulative hour/week during one\'s lifetime. Non‐animal‐exposed controls with no self‐reported household and occupational animal exposure were recruited from the capital city of Ulaanbaatar.

![Country map of Mongolia showing aimags (provinces) where animal‐exposed participants were enrolled (1‐Khovd, 2‐Tuv, and 3‐Dornogovi). Most non‐exposed participants were enrolled in the capital city (4‐Ulaanbaatar).](IRV-7-1246-g001){#irv12148-fig-0001}

Laboratory methods {#irv12148-sec-0003}
------------------

Whole blood specimens were transported using cold chain within 24 hours after collection to local field laboratories in Khovd and Dornogovi provinces and to the National Influenza Center of the National Center of Communicable Diseases, in Ulaanbaatar. Upon arrival, blood specimens were accessioned, and serum was separated, aliquoted, and frozen at −80°C. Frozen sera were transported on dry ice to the University of Florida for testing.

Influenza virus strains were selected based upon the hemagglutinin (HA) type for their best geographic and temporal proximity to the study population (Table [1](#irv12148-tbl-0001){ref-type="table-wrap"}). A microneutralization (MN) assay adapted from previous reports by Rowe *et al*.[7](#irv12148-bib-0007){ref-type="ref"}, [8](#irv12148-bib-0008){ref-type="ref"}, [9](#irv12148-bib-0009){ref-type="ref"}, [10](#irv12148-bib-0010){ref-type="ref"}, [11](#irv12148-bib-0011){ref-type="ref"} was used to detect antibodies against a panel of avian and avian‐like influenza A viruses, as well as a Mongolian H3N8 EIV.

###### 

Viruses used in serological studies. Unless otherwise indicated, serologic study was performed using the microneutralization assay

  Avian viruses                                                        Human viruses
  -------------------------------------------------------------------- -----------------------------------------------------------------
  A/Migratory duck/Hong Kong MPS180/2003(H4N6)                         A/Brisbane/59/2007(H1N1)[a](#irv12148-note-0001){ref-type="fn"}
  A/Cygnus/Mongolia/3/2009(H5N1)                                       A/Mexico/4108/2009(H1N1)[a](#irv12148-note-0001){ref-type="fn"}
  A/Nopi/Minnesota/2007/462960‐2(H5N2)                                 A/Brisbane/10/2007(H3N2)[a](#irv12148-note-0001){ref-type="fn"}
  A/Teal/Hong Kong/w312/97(H6N1)                                       
  A/Water fowl/Hong Kong/Mpb127/2005(H7N7)                             **Equine virus**
  A/Migratory duck/Hong Kong/MP2553/2004(H8N4)                         A/Equine/Mongolia/01/2008(H3N8)
  A/Hong Kong/1073/1999(H9N2)[b](#irv12148-note-0002){ref-type="fn"}   
  A/Migratory duck/Hong Kong/MPD268/2007(H10N4)                        

Virus studied with hemagglutination inhibition assay.

Virus of avian origin but isolated from a human.
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Due to a low prevalence of elevated antibodies against the various avian and equine influenza viruses, rapidly waning titers,[12](#irv12148-bib-0012){ref-type="ref"} and the inability to determine when an infection might have occurred, a low threshold of antibody titer (≥1:10) was chosen as evidence of previous infection with a strain of EIV or AIV. Additionally, cross‐reactions from previous infection with human influenza viruses might confound the serology; therefore, potential confounding was controlled by also testing sera for antibodies against three human influenza viruses, using the hemagglutination inhibition (HI) assay as previously described.[13](#irv12148-bib-0013){ref-type="ref"}, [14](#irv12148-bib-0014){ref-type="ref"} A HI titer ≥1:40 was used as a cut point in including elevated antibody against human virus for multivariate modeling. MN and HI assay methods are reported as supplemental information.

Statistical methods {#irv12148-sec-0004}
-------------------

Analyses were performed using [sas]{.smallcaps}, version 9.2 (SAS Institute, Inc., Cary, NC, USA). Comparisons of participant demographics between the exposure groups were made using binary logistic regression. An exact conditional method was used for sparse data.

Results {#irv12148-sec-0005}
=======

Between January and June, 2009, 439 participants were enrolled: 358 (81·5%) reported household and/or occupational exposure to animals, and 81 (18·5%) were non‐animal‐exposed subjects. The cohort\'s median age was 39, and 52·2% were male (Table [2](#irv12148-tbl-0002){ref-type="table-wrap"}). Seventeen participants (4·0%) reported having previously received a seasonal influenza vaccine, with five receiving vaccines within a year of study enrollment.

###### 

Characteristics of study subjects upon enrollment, Mongolia, 2009. Unadjusted odds ratio for animal‐exposed participants compared with non‐animal‐exposed against control participants with binary logistic regression

  Variables                                                                                      Total N   Exposed N (%)   Controls N (%)   Unadjusted OR (95% CI)
  ---------------------------------------------------------------------------------------------- --------- --------------- ---------------- -------------------------------------------------------------------------------------------------------
  Age (years)                                                                                                                               
  18--32                                                                                         148       130 (36·3)      22 (27·2)        1·2 (0·6--2·2)
  33--45                                                                                         139       105 (29·3)      34 (42·0)        0·6 (0·4--1·1)
  46--75                                                                                         152       123 (34·4)      25 (30·9)        Ref
  Gender                                                                                                                                    
  Female                                                                                         210       179 (50·0)      31 (38·3)        1·6 (1·0--2·6)
  Male                                                                                           229       179 (50·0)      50 (61·7)        Ref
  Indoor water missing[a](#irv12148-note-0003){ref-type="fn"}                                                                               
  Yes                                                                                            412       353 (99·2)      59 (72·8)        43·3 (12·4--232·8)[b](#irv12148-note-0004){ref-type="fn"} ^,^ [c](#irv12148-note-0005){ref-type="fn"}
  No                                                                                             25        3 (0·8)         22 (27·2)        Ref
  Ever received vaccination for human influenza[a](#irv12148-note-0003){ref-type="fn"}                                                      
  No                                                                                             411       346 (96·7)      65 (92·9)        2·2 (0·6--7·0)[b](#irv12148-note-0004){ref-type="fn"}
  Yes                                                                                            17        12 (3·4)        5 (7·1)          Ref
  Heart disease, hypertension, or stroke[a](#irv12148-note-0003){ref-type="fn"}                                                             
  Yes                                                                                            72        68 (19·0)       4 (6·1)          3·6 (1·3--10·3)^c^
  No                                                                                             352       290 (81·0)      62 (93·4)        Ref
  Chronic breathing problems[a](#irv12148-note-0003){ref-type="fn"}                                                                         
  Yes                                                                                            43        38 (10·6)       5 (7·3)          1·5 (0·6--4·0)
  No                                                                                             384       320 (89·4)      64 (92·8)        Ref
  Other chronic medical problems[a](#irv12148-note-0003){ref-type="fn"}                                                                     
  Yes                                                                                            65        58 (16·3)       7 (10·0)         1·8 (0·8--4·0)
  No                                                                                             361       298 (83·7)      63 (90·0)        Ref
  Ever used tobacco products[a](#irv12148-note-0003){ref-type="fn"}                                                                         
  Yes                                                                                            115       100 (27·9)      15 (22·1)        1·4 (0·7--2·5)
  No                                                                                             311       258 (72·1)      53 (77·9)        Ref
  Developed a respiratory illness in the last 12 months[a](#irv12148-note-0003){ref-type="fn"}                                              
  Yes                                                                                            190       159 (44·4)      31 (44·9)        1·0 (0·6--1·6)
  No                                                                                             237       199 (55·6)      38 (55·1)        Ref

Covariate has some missing data.

Fisher\'s exact method used.

Statistically significant data (*P* \<0·05).
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For the 358 animal‐exposed participants, lifetime animal exposure included the following: horses (76·0%), camels (39·4%), goats (55·0%), sheep (49·4%), cattle (48·3%), pigs (15·4%), and domestic poultry (9·5%). The majority (91%) of the exposed participants reported their animal exposures to have occurred recently (since 2003). Seventy‐five participants (17·1%) reported recent disease outbreaks in their horses or camels.

Elevated MN titers against EIV were sparse. Enrollment sera from four participants had elevated antibody titers against A/Equine/Mongolia/01/2008(H3N8; Table [3](#irv12148-tbl-0003){ref-type="table-wrap"}); of which 3 (75%) had a titer of 1:10 and reported recent occupational exposure to horses. One participant was a 27‐year‐old male who had been a horse and camel herder for the last 10 years. The other two participants were members of the same family household (47‐year‐old male and 46‐year‐old female), and both had been horse herders for the last 18 years. All three participants reported recent disease outbreaks in their equine herds and also farmed cattle, sheep, and goats. While none reported ever receiving a seasonal influenza vaccine, all three had elevated antibody titers (≥1:40) against the A/Brisbane/10/2007(H3N2) human influenza virus.

###### 

Distribution of elevated MN titers against equine and avian influenza viruses and HI titers against human influenza among seropositive study participants in Mongolia

  Participant          A/Equine/Mongolia /01/2008(H3N8)   A/Cygnus/Mongolia/3/2009(H5N1)   A/Teal/Hong Kong/ w312/97(H6N1)   A/Hong Kong/1073/ 1999(H9N2)   A/Brisbane/10/ 2007(H3N2)
  -------------------- ---------------------------------- -------------------------------- --------------------------------- ------------------------------ ---------------------------
  27‐year‐old male     10                                 \<10                             \<10                              \<10                           320
  47‐year‐old male     10                                 \<10                             \<10                              \<10                           40
  46‐year‐old female   10                                 \<10                             \<10                              \<10                           40
  32‐year‐old female   20                                 \<10                             10                                \<10                           160
  69‐year‐old male     \<10                               10                               \<10                              \<10                           80
  52‐year‐old male     \<10                               \<10                             \<10                              10                             80
  63‐year‐old male     \<10                               \<10                             \<10                              10                             \<10
  23‐year‐old male     \<10                               \<10                             \<10                              10                             \<10

MN, Microneutralization assay; HI, Hemagglutination inhibition assay.
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The fourth EqH3N8 seropositive (1:20) participant was a 32‐year‐old female who worked as a national health official. While she reported working with cows for the last 17 years and pigs for the last 2 years, she reported no exposure to horses or camels. Furthermore, this participant also had an elevated titer (1:10) against the A/Teal/Hong Kong/w312/97(H6N1) AIV; she was the only seropositive subject. She reported no exposure to poultry or wild birds. She did report receiving a seasonal influenza vaccine in 2006 and was seropositive (1:160) against A/Brisbane/10/2007(H3N2). She reported experiencing 1--2 episodes of a respiratory illness (fever and cough or sore throat) in the 30 days prior to her enrollment and reported 3--5 episodes of respiratory illness among household family members (six adults and two children) within the same time period.

Seroreactivity against the remaining AIV strains was also very sparse. Three participants had elevated titers (1:10) against A/Hong Kong/1073/1999(H9N2). One participant had a prior 4‐year history of household exposure to chickens, but none cited recent poultry or wild bird exposure. Only one AvH9N2 seropositive participant was also seropositive against A/Brisbane/10/2007(H3N2), and all three reported never receiving an influenza vaccination.

One participant, a 69‐year‐old male, had an elevated antibody titer (1:10) against A/Cygnus/Mongolia/3/2009(H5N1) HPAI virus. This participant was a herder of horses, camels, sheep, goats, and cattle, but he reported no poultry or wild bird exposure. He had never received an influenza vaccine, but he did have an elevated antibody titer (1:80) against A/Brisbane/10/2007(H3N2).

In examining serological reactivity against human influenza virus strains, 287 participants (65·8%) had elevated titers (≥1:40) against A/Brisbane/10/2007(H3N2). Forty‐two participants (9·6%) had elevated titers against A/Brisbane/59/2007(H1N1). Seven participants (1·6%) had elevated titers against the 2009 pandemic influenza virus, A/Mexico/4108/2009(H1N1). Six of the seven were enrolled in May--June 2009, and one participant was enrolled in January 2009.

Discussion {#irv12148-sec-0006}
==========

A 1966 report by US National Institutes of Health researchers clearly documented experimental EIV infections in humans.[6](#irv12148-bib-0006){ref-type="ref"} While 4 (12%) of 33 inoculated subjects experienced clinical illness, 20 subjects (61%) had evidence of infection by an observed antibody titer increase. As Mongolia has large populations of horses that roam its vast plains, comingling with aquatic birds that occasionally introduce HPAI, it seems prudent to study Mongolia\'s rural people for evidence of zoonotic influenza virus infection.

Our study data, and human influenza surveillance data in Mongolia, suggest that if AIV or EIV infections occur in Mongolians, they likely occur infrequently. It seems possible that the low MN titers detected might reflect EIV infections during the 2007--2008 H3N8 equine epizootic that had waned[12](#irv12148-bib-0012){ref-type="ref"} by human blood draw in 2009. However, it seems equally plausible that the low tiers may be explained by cross‐reactivity from previous human influenza A virus infection, especially that due to human H3N2 virus.

The sparse serological evidence for human EIV and AIV infections in this study population suggests that neither EIV nor AIV are currently posing a significant human health risk to rural Mongolians. Nevertheless, Mongolia with its large populations of horses and migrating birds seems an important place to continue to conduct surveillance for the emergence of novel influenza strains.
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**Data S1.**Influenza serological assay methods.

###### 

Click here for additional data file.
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